Skip to main content
Loading ResearchHub…
Cited by — Targeting SLC38A5 Overcomes αPD-1 Immunotherapy Resistance by Alleviating Glutamine Competition Between Glioblastoma Cells and T Cells | ResearchHub - ResearchHub